168 related articles for article (PubMed ID: 32355807)
1. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients.
Fei H; Chen S; Xu C
Ann Transl Med; 2020 Mar; 8(6):363. PubMed ID: 32355807
[TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways.
Fei H; Chen S; Xu C
J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821
[TBL] [Abstract][Full Text] [Related]
4. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
Zhai X; Yang Z; Liu X; Dong Z; Zhou D
PeerJ; 2020; 8():e9975. PubMed ID: 33005492
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.
Alam MS; Sultana A; Wang G; Haque Mollah MN
Front Mol Biosci; 2022; 9():1049741. PubMed ID: 36567949
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.
Ren Y; Deng R; Zhang Q; Li J; Han B; Ye P
Ann Transl Med; 2020 Dec; 8(24):1637. PubMed ID: 33490149
[TBL] [Abstract][Full Text] [Related]
10. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.
Wang Y; Li H; Ma J; Fang T; Li X; Liu J; Afewerky HK; Li X; Gao Q
Onco Targets Ther; 2019; 12():8401-8410. PubMed ID: 31632087
[TBL] [Abstract][Full Text] [Related]
11. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis.
Lin Z; Peng R; Sun Y; Zhang L; Zhang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305312
[TBL] [Abstract][Full Text] [Related]
12. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer.
Cao J; Sun S; Min R; Li R; Fan X; Han Y; Feng Z; Li N
Cancer Manag Res; 2021; 13():9477-9487. PubMed ID: 35002325
[TBL] [Abstract][Full Text] [Related]
14. Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC).
Chuan T; Li T; Yi C
Med Sci Monit; 2020 Jan; 26():e918281. PubMed ID: 31924747
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers.
Kaddoura R; Alqutami F; Asbaita M; Hachim M
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836779
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of human kallikrein 5 (
Song Y; Bai G; Li X; Zhou L; Si Y; Liu X; Deng Y; Shi Y
Cancer Innov; 2023 Oct; 2(5):376-390. PubMed ID: 38090381
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer.
Bissanum R; Kamolphiwong R; Navakanitworakul R; Kanokwiroon K
Transl Cancer Res; 2022 Sep; 11(9):3039-3049. PubMed ID: 36237261
[TBL] [Abstract][Full Text] [Related]
20. Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology.
Liu N; Wang X; Zhu Z; Li D; Lv X; Chen Y; Xie H; Guo Z; Song D
Aging (Albany NY); 2021 Oct; 13(20):23702-23725. PubMed ID: 34686627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]